Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A systems perspective on rare diseases: integrating human phenotype ontology with the Anukta framework of Ayurveda. | J Ayurveda Integr Med | 2026 | 41780100 | PubTator, text mining | PubMed |
| Computational analysis of hub genes associated with sarcopenia: integrative transcriptome insights from an Asian cohort. | EXCLI J | 2026 | 41768858 | PubTator, text mining | PubMed |
| Fading Muscle and a Flaccid Bladder: Atonic Bladder in a Case of Myotonic Dystrophy-A Case Report. | Ann Neurosci | 2026 | 41766784 | PubTator, text mining | PubMed |
| Short tandem repeat expansions in patients with neurodegenerative dementia. | EBioMedicine | 2026 | 41762523 | PubTator, text mining | PubMed |
| Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma. | Sci Adv | 2026 | 41758938 | PubTator, text mining | PubMed |
| Elevated Risk of Endometrial Cancer and Precursor Lesions in Patients With Myotonic Dystrophy: A Retrospective Study at a Single Institution in Japan. | J Obstet Gynaecol Res | 2026 | 41744896 | PubTator, text mining | PubMed |
| RNA cargo profiling of muscle extracellular vesicles identifies candidate biomarkers of disease activity and muscle degeneration in FSHD. | J Transl Med | 2026 | 41742280 | PubTator, text mining | PubMed |
| New Dual Pan-PI3K/mTOR Inhibitor: Design, Synthesis, Cytotoxic Action, Permeation, Metabolic Stability, and In Silico Protein-Ligand Interaction. | ACS Omega | 2026 | 41726721 | PubTator, text mining | PubMed |
| Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1. | Am J Hum Genet | 2026 | 41722569 | PubTator, text mining | PubMed |
| Analyzing the genetic profile of autistic children and adolescents with minimal verbal abilities. | Front Genet | 2026 | 41716258 | PubTator, text mining | PubMed |
| Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1. | NAR Mol Med | 2026 | 41710065 | PubTator, text mining | PubMed |
| An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1. | N Engl J Med | 2026 | 41707138 | PubTator, text mining | PubMed |
| Performance Evaluation of PacBio PureTarget for Multiple Short Tandem Repeat Expansion Detection. | Ann Lab Med | 2026 | 41672630 | PubTator, text mining | PubMed |
| MBNL2 dysfunction in outer radial glial cells is associated with disrupted corticogenesis in congenital myotonic dystrophy. | Neurobiol Dis | 2026 | 41644016 | PubTator, text mining | PubMed |
| Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics. | J Biol Chem | 2026 | 41621483 | PubTator, text mining | PubMed |
| Aberrant skeletal muscle morphogenesis and myofiber differentiation characterize equine myotonic dystrophy. | PLoS One | 2026 | 41610137 | PubTator, text mining | PubMed |
| Discovery of 7-(Pyridin-3-yl)thieno[3,2-b]pyridine-5-carboxamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5. | ACS Chem Neurosci | 2026 | 41582453 | PubTator, text mining | PubMed |
Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy. | ACS Chem Neurosci | 2026 | 41581069 | PubTator, text mining | PubMed |
| Antibodies to watch in 2026. | MAbs | 2026 | 41560619 | PubTator, text mining | PubMed |
| Development of a comprehensive cardiovascular disease genetic risk assessment test. | Genet Med Open | 2026 | 41551008 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers?page=3